scholarly journals New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome

1996 ◽  
Vol 5 (9) ◽  
pp. 1217-1227 ◽  
Author(s):  
A. Engel
2010 ◽  
Vol 20 (9-10) ◽  
pp. 630
Author(s):  
R. Witoonpanich ◽  
T. Pulkes ◽  
C. Dejthevaporn ◽  
P. Yodnopklao ◽  
P. Witoonpanich ◽  
...  

2021 ◽  
Vol 8 (1) ◽  
pp. 163-167
Author(s):  
Inuka Kishara Gooneratne ◽  
Shanika Nandasiri ◽  
Susan Maxwell ◽  
Richard Webster ◽  
Judith Cossins ◽  
...  

Congenital myasthenic syndromes (CMS) result from genetic mutations that cause aberrations in structure and/or function of proteins involved in neuromuscular transmission. The slow-channel CMS (SCCMS) is an autosomal dominant postsynaptic defect caused by mutations in genes encoding alpha, beta, delta, or epsilon subunits of the acetylcholine receptor resulting in a functional defect which is an increase of the opening time of the receptor. We report a case of SCCMS due to a heterozygous mutation in the M2 domain of the AChR alpha subunit - CHRNA1:ENST00000348749.6:exon7:c.806T>G:p.Val269Gly and corresponding kinetic defect. A substitution of valine with phenylalanine in the same position has been previously described. This is the first reported case of a new CHRNA1 variant in a patient with SCCMS from South Asia. We also highlight the phenotype that would favour a genetic basis over an autoimmune one, in an adult presenting with fatigable weakness.


1999 ◽  
Vol 45 (4) ◽  
pp. 439-443 ◽  
Author(s):  
Philip Nichols ◽  
Rebecca Croxen ◽  
Angela Vincent ◽  
Richard Rutter ◽  
Michael Hutchinson ◽  
...  

2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
Jose Gabriel Grajales ◽  
Gary Grajales ◽  
Carlos Baez ◽  
Haipeng Zhu ◽  
Oreste Quesada ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document